As we observed partial restoration of OXPHOS proteins and TOMM20 to normal levels and we noted a rescue of DRP1 expression in MS-444-treated mdx mice, we suggest a potential mitigation of DCM mitochondrial dysfunction following MS-444 treatment. The gene discussed is DNM1L; the disease is familial dilated cardiomyopathy.